Twist1 promotes dendritic cell-mediated antitumor immunity

Area of Science:

• Immunology
• Cancer Biology
• Cell Biology

Background:

• Dendritic cells (DCs) are key players in immune responses, including antitumor immunity.
• Tumor-infiltrating DCs correlate with patient survival and prognosis.
• The role of Twist1 within DCs in regulating antitumor responses is largely unknown.

Purpose of the Study:

• To investigate the function of Twist1 in dendritic cells (DCs) in the context of antitumor immunity.
• To determine how DC-specific Twist1 deficiency impacts immune cell populations and anti-cancer responses in melanoma models.

Main Methods:

• Generation of a mouse model with conditional Twist1 depletion in DCs.
• Analysis of DC and T cell homeostasis under steady-state and tumor conditions.
• Assessment of tumor-infiltrating immune cells and cytokine production (IFN-γ) in melanoma models.

Main Results:

• Twist1 deficiency in DCs did not alter homeostasis under normal conditions.
• In melanoma models, Twist1-deficient DCs led to reduced conventional DCs (cDCs) in draining lymph nodes and tumors.
• This reduction impaired T cell infiltration and decreased IFN-γ production, dampening antitumor T cell functions.

Conclusions:

• Twist1 in dendritic cells is essential for maintaining the number of tumor-infiltrating DCs and T cells.
• DC-derived Twist1 plays a critical role in regulating T cell-mediated antitumor activity.
• Targeting Twist1 in DCs may represent a strategy to enhance anti-cancer immune responses.